Boundless Bio, Inc. financial statements
Boundless Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 58.2M | 10-K |
| Cash and equivalents | USD 17.87M | 10-Q |
| Total debt | USD 49.03M | EODHD |
Boundless Bio, Inc. financials on 6ix · Boundless Bio, Inc. on 6ix